Mark Mauldin compensation by year
Silicon Laboratories Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $331,000 |
| Bonus | $50,000 |
| Stock awards | $1,085,778 |
| Option awards | $0 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $6,292 |
| Total | $1,473,070 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Silicon Laboratories, Inc. DEF 14A filed March 12, 2025, accession 0001193125-25-052915, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Silicon Laboratories, Inc. filed document, accession 0001193125-25-052915. Every figure is read from that document and cited to the page and table it appears in. Filed March 12, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 3,993 | $510,226 | — |
| RSU | 3,948 | $504,475 | — |
| RSU | 2,133 | $272,555 | — |
| RSU | 1,214 | $155,125 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Silicon Laboratories, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
8 Form 4 lines since the FY2024 proxy (filed March 12, 2025)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-15 | Tax withholding | — | 858 | $216.59 | 21,090 |
| 2026-04-30 | Grant or award | — | 18 | $86.46 | 21,948 |
| 2026-02-15 | Grant or award | — | 3,153 | $0.00 | 21,930 |
| 2026-02-13 | Tax withholding | — | 356 | $207.27 | 18,777 |
| 2025-10-31 | Grant or award | — | 21 | $86.46 | 19,133 |
| 2025-05-15 | Grant or award | — | 2,456 | $0.00 | 19,990 |
| 2025-05-15 | Tax withholding | — | 878 | $133.17 | 19,112 |
| 2025-04-30 | Grant or award | — | 19 | $86.46 | 17,534 |
The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Silicon Laboratories discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $335,000 | $1,442,381 | $46,377 | $1,957,758 |
Per the Potential Payments Upon Termination or Change in Control table in Silicon Laboratories, Inc.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
Silicon Laboratories’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| R. Matthew Johnson | President and Chief Executive Officer | $7,209,463 |
| Dean Butler | Senior Vice President and Chief Financial Officer | $6,142,410 |
| Robert Conrad | Senior Vice President of Worldwide Operations | $3,561,097 |
| Brandon Tolany | Senior Vice President of Worldwide Sales | $2,808,862 |
| Mark Mauldin · this page | Current Chief Accounting Officer and former Interim Chief Financial Officer | $1,473,070 |
| John Hollister | Former Senior Vice President and Chief Financial Officer | $43,387 |
The full Silicon Laboratories compensation record
free company briefThis page is one person within Silicon Laboratories's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Silicon Laboratories proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Silicon Laboratories's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.